THERAPEUTIC PROPERTIES OF CANNABIDIOL

 

Currently, numerous studies and clinical trials are being carried out to verify the medicinal properties of cannabidiol. To date, with different quality of evidence, the following properties have been demonstrated:

  • It is already used in children and adults with refractory epilepsies that do not respond to other treatments.
  • According to a study published in the European Journal of Pain, its effects on the nervous system can help reduce pain in patients with rheumatoid arthritis.
  • There is a study published in the journal Neurotherapeutics that supports the beneficial effects of taking doses of between 300 and 600 mg of CBD to reduce anxiety and fear.
  • There are studies, such as one carried out by Queen's University, that seem to show that it is effective in the treatment of Parkinson's, and there are others that relate it to an improvement in Alzheimer's. However, there is still not enough evidence.
  • Anti-nausea and antiemetic. It has been tested in cancer patients who have nausea and vomiting from chemotherapy.

Although these are the main properties, there are other studies that associate the consumption of CBD with improved sleep, better healing or a reduction in blood pressure. However, in all these cases further investigation still needs to be carried out.

Health benefits

In general, the different clinical studies that are being carried out show that it has therapeutic potential for the following pathologies:

  • Chronic pain.
  • Fibromyalgia.
  • Certain types of cancer.
  • Autoimmune inflammatory diseases.
  • Anxiety, stress and depression.
  • Neurological disorders.
  • Neuropsychiatric diseases.
  • metabolic syndromes.
  • Post-traumatic stress disorder and alcoholism.
  • Cardiovascular disorders.
  • Inflammatory bowel diseases
  • Chronic inflammatory skin diseases.

Currently, cannabidiol is presented in formats such as oil, capsules, creams, shampoos, ointments, etc. However, in Spain their use and consumption is only allowed if they are cosmetic products. Furthermore, it can only be marketed if its THC level is below 0.2%. This may change in the coming years, since in 2020 the Health Commission of the Congress of Deputies created a subcommittee to regulate the use of cannabis for medicinal purposes.